Additionally, high SLC12A5 expression was considerably positively correlated with MSI in BLCA, BRCA, and PRAD, but significantly negatively correlated in GBM, PAAD, SKCM, STAD, and UCEC. Here, SLC12A5 is linked to prostate adenocarcinoma.